PIH21 VALIDATION AND COMPARISON OF EUROQOL AND SHORT FORM 6D IN CHINESE CHRONIC PROSTATITIS PATIENTS
Zhao FL 1 , Yue M 2 , Wu JH 2 , Yang H 3 , Wang T 3 , Li SC 1 1 University of Newcastle, Callaghan, N.S.W., Australia, 2 Hospital of PLA, Beijing, Beijing, China, 3 The First People's Hospital of Yunnan Province, Kunming, Yunnan, China OBJECTIVES: Generic, preference-based Health-related Quality of Life (HRQoL) instruments are increasingly used in decision-making process of clinicians and policymakers. However, no such HRQoL instrument has been validated or used in Chronic Prostatitis (CP), in which a goal of patient management is to improve the HRQoL. We therefore aimed to assess and compare the psychometric properties of EuroQol (EQ-5D) and Short Form 6D (SF-6D) among CP patients in China. METHODS: Consenting CP patients were interviewed using EQ-5D and SF-6D. Convergent and discriminative construct validities were examined with five and two a priori hypotheses respectively. Sensitivity was compared using receiver operating characteristic (ROC) curves and relative efficiency (RE) statistics. Agreement between instruments was assessed with intra-class correlation coefficients (ICCs) and Bland-Altman plot, while factors affecting utility difference were explored with multiple liner regression models. RESULTS: In 268 CP patients (median age 32 years) who completed the interview, mean ± SD EQ-5D and SF-6D utility scores were comparable at 0.74 ± 0.13 and 0.75 ± 0.09 respectively. Five of the seven hypotheses for construct validity were fulfilled in both instruments. The areas under ROC all exceeded 0.5 (P < 0.001), suggesting that the instruments are sensitive to detect clinically relevant differences in CP patients, with SF-6D having 9.7-19.9% higher efficiency at detecting difference in CP symptom severity. Despite no significant difference in paired comparisons of utility scores between the 2 instruments, lack of agreement was observed with low ICC (0.218-0.630) and Bland-Altman plot analysis. CP symptom severity significantly (P < 0.05) influenced differences in utility scores between EQ-5D and SF-6D. CONCLUSIONS: EQ-5D and SF-6D are demonstrated to be valid and sensitive HRQoL measures in Chinese CP patients, with SF-6D showing better HRQoL dimension coverage, greater sensitivity and lower ceiling effect. Further research is needed to determine other psychometric properties, such as longitudinal response and reliability. Pearson correlation coefficients were computed between the BII scores across visits and the other measures. T-tests and general linear modeling compared BII scores of subjects with global ratings of improvement versus no improvement, and between subjects taking Tadalafil versus placebo. RESULTS: There were strong correlations of BII with subjective measures (IPSS, IPSS QOL, LUTS-GAQ) and low correlations of BII with objective measures (Qmax, PVR) were observed in this analysis. There were also statistically significant differences in BII at the End-of-Study Visit between subjects who improved versus subjects with no improvement (Studies 1 and 2, p < .0001) and between subjects taking Tadalafil versus subjects taking placebo (Study 1, p = 0.0088; Study 2, p = 0.0092). CONCLUSIONS: Results demonstrate that BII is reliable and has construct validity. BII is well correlated with subjective measures and less correlated with objective measures, which is confirmatory of literature findings. It is a valuable measure of the impact of BPH symptoms on health and functioning that can be useful in determining treatment options and outcomes for men with BPH. 
PIH23 OVERVIEW OF THE DEVELOPMENT PHASES OF THE OXFORD ANKLE FOOT QUESTIONNAIRE FOR CHILDREN

METHODS:
The development of the questionnaire was conducted in three phases. First the items were devised through focus groups with children affected by foot and ankle problems, and their parents. Second, test versions of child and parent (caregiver) questionnaires were evaluated to enable scales to be developed; three scales were identified and shown to be valid and reliable: Physical (6 items), Emotional (4 items), and School & Play (4 items). Finally, a prospective study was conducted with trauma and elective patients to assess how the scale scores change over time and/or with treatment. RESULTS: In our prospective study for the assessment of trauma patients, mean changes in percentage scores were as expected large and all effect sizes were large (>0.8). For elective patients, the mean improvement in scores and effect sizes were moderate. The Minimal Detectable Change (MDC90) ranged from 6 to 8 on the percent scores. The Minimal Important Difference (MID) for elective patients ranged from 7 to 17%. Half the standard deviation of baseline domain scores (often equated to MID) ranged from 11 to 18 on the percent scale. CONCLUSIONS: The results from the study demonstrated the longitudinal validity and responsiveness of the domain scales. The Questionnaire uniquely offers an expedient and budget conscious means to evaluate the effectiveness of the treatment of children's foot or ankle problems from both the child and parent/caregivers perspective. The questionnaire has broad utility both in routine clinical settings, or applied research to evaluate treatment programmes and interventions used in paediatric orthopaedics, trauma and rheumatology.
